T0	Interventions 73 101	NMDA antagonist AR-R15896AR.
T1	Interventions 189 239	N-Methyl-D-Aspartate (NMDA) antagonist AR-R15896AR
T2	Interventions 569 587	placebo-controlled
T3	Interventions 825 870	Two loading doses of 3.5 mg/kg of AR-R15896AR
T4	Interventions 1540 1551	AR-R15896AR
T5	Interventions 1569 1576	placebo
T6	Interventions 1641 1652	AR-R15896AR
T7	Interventions 1677 1684	placebo
T8	Interventions 1798 1809	AR-R15896AR
T9	Interventions 1883 1895	AR-R15896AR:
T10	Interventions 2289 2300	AR-R15896AR
T11	Interventions 2408 2419	AR-R15896AR
T12	Interventions 2551 2558	placebo